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evidence-based answers from the  
family physicians inquiries network
	 Do	OTC	remedies	relieve	
cough	in	acute	URIs?	
Evidence summary
A	Cochrane	review	found	DM	to	be	modestly	
effective	in	2	of	3	studies.1	In	the	first	study—a	
meta-analysis	of	6	industry-sponsored	RCTs	
of	 710	 adults—a	 single	 30-mg	 dose	 of	 DM	
decreased	 coughing	bouts	by	 12%	 (P=.004)	
and	 increased	 the	 time	 between	 bouts	 by	
17	%	(P=.002)	in	the	3	hours	after	treatment.
A	second	study	of	3	successive	industry-
sponsored,	blinded	RCTs	enrolling	a	total	of	
451	adults	found	that	30	mg	of	DM	decreased	
cough	counts	between	19%	and	36%	(P<.05)	
over	a	3-hour	follow-up	period.	Neither	of	the	
2	studies	specified	whether	the	outcome	as-
sessors	were	blinded	to	treatment	groups.
EvidEncE-basEd answEr
A	 Some do. Dextromethorphan		 (DM)	 for	adults	and	honey	 for	chil-
dren	 provide	 some	 relief.	 DM	 may	 mod-
estly	 decrease	 cough	 in	 adults	 compared	
with	placebo	(strength	of	recommendation	
[SOR]:	B,	 systematic	review	of	 inconsistent	
or	 limited	 evidence).	 The	 data	 support-
ing	 zinc	 for	 the	 common	 cold	 are	 mixed	
(SOR:	 B,	 meta-analysis	 with	 inconsistent	
results).	 Antihistamines,	 antihistamine-	
decongestant	combinations,	and	guaifenesin	
don’t	provide	greater	relief	than	placebo	in	
adults	(SOR:	B,	systematic	review	of	incon-
sistent	or	limited	evidence).
In	 children,	 antihistamines,	 deconges-
tants,	 DM,	 or	 combinations	 of	 them	 don’t	
relieve	 cough	 better	 than	 placebo	 (SOR:	A,	
systematic	review).	Honey		may		modestly	de-
crease	frequency	and	severity	of	cough	com-
pared	with	DM	or	no	treatment	(SOR:	B,	small,	
randomized	controlled	trial	[RCT]).
Clinical commentary
It appears that all of the common, trouble-
some symptoms of an upper respiratory 
infection can be managed just as well with 
over-the-counter (OTC) medications as with 
prescriptions: DM for cough; acetaminophen 
or naproxen sodium for fever and aches; de-
congestants or vapor rubs for nasal conges-
tion. Spread the word!
It would be wonderful if the office visit 
for upper respiratory infection became a 
rarity—the health care system would save 
a lot of money. Presumably, patients would 
still come in wondering if they had some-
thing worse than a cold, but education  
during the first visit would help prevent re-
peat trips.
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A	third	double-blinded	RCT	evaluating	a	
single	30-mg	dose	of	DM	in	43	adults	during	
a	3-hour	follow-up	period	showed	no	statisti-
cally	 significant	 improvement	 in	cough	out-
comes	compared	with	placebo.
A split decision on guaifenesin
The	 same	 Cochrane	 review	 also	 evaluated	
other	medications	for	cough	related	to	upper	
respiratory	infection	in	adults.1	The	results	of	
2	guaifenesin	 trials	were	split.	 In	a	double-
blinded	RCT	of	239	adults,	more	patients	tak-
ing	 guaifenesin	 reported	 decreased	 cough	
frequency	and	intensity	(75%	vs	31%;	P<.01).	
However,	 another	 double-blinded	 RCT	 of	
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nor	diphenhydramine	relieved	cough	better	
than	placebo.
Two	RCTs	involving	a	total	of	237	children	
compared	antihistamines	with	placebo.	One	
double-blinded	trial	reported	that	clemastine	
and	 chlorpheniramine	were	 no	more	 effec-
tive	than	placebo.	The	other	partially	double-
blinded	 trial	 found	 that	 diphenhydramine	
didn’t	decrease	cough	 frequency	more	 than	
placebo.
Two	 double-blinded	 RCTs	 (total	 of	
155	 children)	 showed	 that	 antihistamine-
decongestant	 combinations	 (bromphen-
iramine-phenylpropanolamine	 and	 brom-	
pheniramine-phenylephrine-propano-
lamine)		 	didn’t		 	reduce		cough	more		than	
placebo.	No	studies	have	evaluated	guai-fen-
esin	in	children.1
Honey appears to help
In	 a	 partially	 double-blinded	 RCT	 (the	 “no	
treatment”	 group	 was	 not	 blinded)	 of	 105	
children,	 a	 single	 dose	 of	 buckwheat	 honey	
decreased	 cough	 frequency,	 as	 assessed	 by	
parents,	by	1.89	points	on	the	7-point	Likert	
scale	compared	with	DM	(1.39)	and	no	treat-
ment	(0.92;	P<.001).	Overall	improvement	in	
symptom	score	averaged	10.71	out	of	a	total	
30	points	 for	honey	 compared	with	 6.41	 for	
no	 treatment	 (P=.04).	Cough	 frequency	and	
overall	symptom	scores	for	DM	didn’t	differ	
significantly	 from	no	 treatment.	Hyperactiv-
ity,	nervousness,	and	insomnia	were	report-
ed	more	 often	with	 honey	 (5	 patients)	 than	
DM	(2	patients)	or	no	treatment	(0	patients);	
(P=.04).4
Placebos work, but why?
In	a	review	of	8	RCTs,	the	average	reduction	
in	cough	in	the	placebo	group	(both	capsules	
and	 syrups)	 was	 approximately	 85%	 of	 that	
seen	 in	 the	 active	medication	 group	 (range	
56%-105%).5	Several	 factors	may	account	 for	
the	efficacy	of	placebo,	including	lubrication	
of	the	pharynx	by	increased	salivation	caused	
by	 sweet	 or	 bitter	 vehicles.	 Sweet	 vehicles	
also	may	stimulate	endogenous	opioids	that	
may	 suppress	 cough.	 In	 an	 unblinded	 RCT	
of	54	patients,	a	capsule	placebo	significant-
ly	decreased	the	number	of	coughs	during	a	
15-minute	follow-up	compared	with	no	treat-
ment	(18	vs	3;	P=.0003).6
65	patients	found	guaifenesin	to	be	no	more	
effective	than	placebo	in	reducing	subjective	
cough	frequency.
Antihistamines don’t help, adding 
a decongestant isn’t much better
Three	 trials	 of	 antihistamines	 in	 a	 total	 of	
1900	 adults	 found	 that	 the	 drugs	 didn’t	 re-
lieve	cough	symptoms	more	effectively	than	
placebo.	 Antihistamine-decongestant	 com-
bination	 trials	 produced	 split	 results.	 In	
1	double-blinded	RCT	of	 283	 adults,	 lorata-
dine-pseudoephedrine	(5	and	120	mg,	respec-
tively)	 twice	daily	 for	4	days	didn’t	decrease	
subjective	 cough	 scores	more	 than	 placebo	
and	was	associated	with	more	dry	mouth,	diz-
ziness,	headache,	and	insomnia	(30%	vs	21%;	
P	value	not	reported).
Another	partially	double-blinded	RCT	of	
73	adults	reported	that	dexbrompheniramine-
pseudoephedrine	(6	and	120	mg,	respectively)	
twice	 daily	 for	 1	 week	 decreased	 subjective	
cough	severity	(1.4	vs	2.0;	P<.05)	on	a	scale	of	
0	to	4	during	days	3	to	5	of	treatment.	The	com-
bination	was	associated	with	increased	dizzi-
ness	and	dry	mouth,	however	(exact	data	not	
reported;	P≤.01).
Codeine works no better than placebo
Two	 partially	 double-blinded	 RCTs	 of	 163	
adults	found	codeine	(sold	OTC	in	Canada)	to	
be	no	more	effective	than	placebo	in	relieving	
cough	caused	by	the	common	cold.1
Zinc lozenges show  mixed results
Zinc	lozenges	containing	13.3	mg	of	zinc	ace-
tate	taken	every	2	to	3	hours	decreased	the	du-
ration	of	cough	from	5.35	to	2.14	days	(P<.001)	
in	a	double-blinded	placebo-controlled	RCT	
of	50	adults.2	The	most	recent	systematic	re-
view	showed	mixed	results:	Half	 the	studies	
found	no	benefit	for	zinc	in	treating	upper	re-
spiratory	infection.3
In children, forget DM, antihistamines,  
decongestants
The	 previously	 mentioned	 Cochrane	 re-
view1	 also	 summarized	 studies	 in	 children.	
DM	was	no	more	 effective	 than	placebo	 for	
decreasing	 cough	 in	 2	 RCTs	 enrolling	 a	 to-
tal	 of	 107	 children.	 Another	 single-blinded	
RCT	of	100	children	showed	that	neither	DM	
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Recommendations 
The	American	College	of	Chest	Physicians	
recommends	a	first-generation	antihista-
mine-decongestant	combination	or	naproxen	
for	acute	cough	in	the	common	cold	(SOR:	
A).	Newer-generation,	nonsedating	antihis-
tamines	are	not	recommended	(SOR:	D).7
The	 US	 Food	 and	 Drug	 Administration	
(FDA)	advises	against	using	OTC	cough	and	
cold	 medicines	 in	 children	 younger	 than	
2	 years	 because	 of	 the	 risk	 of	 “serious	 and	
potentially	 life-threatening	side	effects.”	The	
FDA	also	recommends	taking	significant	pre-
cautions	if	these	products	are	used	in	children	
older	than	2	years,	pending	a	complete	FDA	
review	of	the	medications	for	children	2	to	11	
years.	Manufacturers	of	children’s	cough	and	
cold	remedies	have	changed	the	labels	on	the	
medications	 voluntarily	 to	 recommend	 that	
they	 not	 be	 given	 to	 children	 younger	 than	
4	years.8
The	 American	 Academy	 of	 Pediatrics	
recommends	that	physicians	clearly	educate	
parents	 about	 the	 potential	 risks	 and	 lack	
of	 benefits	 of	 DM-	 and	 codeine-containing	
cough	remedies.9		 	 														
The FDA advises 
against giving 
OTC cough and 
cold medicine to 
children younger 
than 2 years.
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